The researchers also reveal the first mechanism of NMDA receptor activation integrating functional evidence obtained in ...
The FDA approved combination dextromethorphan and bupropion extended-release tablets (Auvelity) for adults with major depressive disorder (MDD), Axsome Therapeutics announced on Friday.